Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LivaNova PLC | 12,910 | reported | 15 Jun 2025 | tx 41+45,153−31,016 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2025 | TAX_WITHHOLDING | LivaNova PLC | 1,606 | 45.76 USD | |
| 15 Jun 2025 | EXERCISE | LivaNova PLC | 3,416 | 0.00 USD | |
| 15 Jun 2025 | GRANT_AWARD | LivaNova PLC | 4,042 | 0.00 USD | deriv |
| 15 Jun 2025 | EXERCISE | LivaNova PLC | 3,416 | 0.00 USD | deriv |
| 15 Jun 2024 | TAX_WITHHOLDING | LivaNova PLC | 1,260 | 52.68 USD | |
| 15 Jun 2024 | EXERCISE | LivaNova PLC | 2,680 | 0.00 USD | |
| 15 Jun 2024 | GRANT_AWARD | LivaNova PLC | 3,416 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | LivaNova PLC | 2,680 | 0.00 USD | deriv |
| 15 Jun 2023 | TAX_WITHHOLDING | LivaNova PLC | 979 | 48.40 USD | |
| 15 Jun 2023 | EXERCISE | LivaNova PLC | 2,082 | 0.00 USD | |
| 15 Jun 2023 | EXERCISE | LivaNova PLC | 2,082 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | LivaNova PLC | 2,680 | 0.00 USD | deriv |
| 15 Jun 2022 | TAX_WITHHOLDING | LivaNova PLC | 636 | 59.94 USD | |
| 15 Jun 2022 | EXERCISE | LivaNova PLC | 1,346 | 0.00 USD | |
| 15 Jun 2022 | EXERCISE | LivaNova PLC | 1,346 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | LivaNova PLC | 2,082 | 0.00 USD | deriv |
| 29 Jun 2021 | EXERCISE | LivaNova PLC | 2,337 | 0.00 USD | |
| 29 Jun 2021 | TAX_WITHHOLDING | LivaNova PLC | 1,099 | 85.43 USD | |
| 29 Jun 2021 | EXERCISE | LivaNova PLC | 2,337 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | LivaNova PLC | 1,346 | 0.00 USD | deriv |
| 29 Jun 2020 | GRANT_AWARD | LivaNova PLC | 2,337 | 0.00 USD | deriv |
| 18 Jun 2020 | EXERCISE | LivaNova PLC | 1,500 | 0.00 USD | |
| 18 Jun 2020 | TAX_WITHHOLDING | LivaNova PLC | 705 | 48.29 USD | |
| 18 Jun 2020 | EXERCISE | LivaNova PLC | 1,500 | 0.00 USD | deriv |
| 18 Jun 2019 | GRANT_AWARD | LivaNova PLC | 1,500 | 0.00 USD | deriv |